|1.||Lopes, José Daniel: 3 articles (03/2006 - 08/2003)|
|2.||Mariano, Mario: 2 articles (03/2006 - 10/2003)|
|3.||Navarro, Italmar T: 1 article (08/2013)|
|4.||Omori, Aline M: 1 article (08/2013)|
|5.||Oliveira, Gabriela G: 1 article (08/2013)|
|6.||Ono, Mario A: 1 article (08/2013)|
|7.||Ferreira, Jacqueline B: 1 article (08/2013)|
|8.||Camargo, Zoilo P: 1 article (08/2013)|
|9.||Belitardo, Donizeti R: 1 article (08/2013)|
|10.||Itano, Eiko N: 1 article (08/2013)|
|1.||Paracoccidioidomycosis (South American Blastomycosis)
08/01/2003 - "Detection of circulating gp43 antigen in serum, cerebrospinal fluid, and bronchoalveolar lavage fluid of patients with paracoccidioidomycosis."
03/01/1995 - "Lack of reactivity of paracoccidioidomycosis sera in the double immunodiffusion test with the gp43 antigen: report of two cases."
08/01/2013 - "The humoral immune response to the gp43 antigen, the main antigen used for paracoccidioidomycosis serodiagnosis and seroepidemiology, was evaluated in two goats immunized with inactivated P. "
04/01/2007 - "By using a TEPITOPE algorithm, we selected and analyzed the T-cell responses of peripheral blood mononuclear cells from 29 paracoccidioidomycosis (PCM) patients to peptides of the immunodominant gp43 antigen of Paracoccidioides brasiliensis, the causative agent of PCM."
09/01/1991 - "Both forms are equally resistant to endogenous proteases at neutral pH. The gp43, itself, has a proteolytic activity at pH 5-6, but not at neutral pH. Deglycosylation with endoglycosidase H or tunicamycin preserved epitopes in the 38-kDa molecule reactive with (a) antibodies from patients with paracoccidioidomycosis, or rabbit immunized with the gp43 and (b) mouse monoclonal antibodies against the gp43 antigen. "
|2.||Melanoma (Melanoma, Malignant)
07/01/1998 - "Augmentation of IgM antibody to gp43 tumor-associated antigen peptide by melanoma cell vaccine."
07/01/1998 - "We previously reported that gp43 tumor-associated antigen peptide (DLTMKYQIF; designated 810 antigen) on human melanoma cells is recognized by IgM human monoclonal antibody L92 and by cytotoxic T lymphocytes (CTL). "
06/15/1997 - "Recognition of gp43 tumor-associated antigen peptide by both HLA-A2 restricted CTL lines and antibodies from melanoma patients."
|3.||HLA-A2 Antigen (HLA A2 Antigen)
|6.||Peptide Hydrolases (Proteases)
|7.||Immunoglobulin M (IgM)